American Vanguard Completes Significant Product Acquisitions
American Vanguard Corporation (NYSE:AVD), today announced that its wholly owned subsidiary AMVAC Chemical Corporation has
completed the acquisition of three crop protection product lines – abamectin, chlorothalonil and paraquat – from Adama Agricultural
Solutions Ltd., which is part of the China National Chemical Corporation (“ChemChina”) group. As reported on April 5, 2017, these
product lines were sold pursuant to the terms of a consent decree from the FTC, as a condition for that agency’s approval of the
ChemChina/Syngenta merger. The acquisition includes the trademarks, product registrations, registration data, and commercial
information that relate to the marketing and sale of these three product lines in the crop protection market within the United
States. Financial details of the transaction were not disclosed.
Eric Wintemute, Chairman & CEO of American Vanguard commented: “Adding these proven, branded product lines will diversify
and balance our crop and geographical segments, while adding sales opportunities for our channel partners and continued growth for
our business. In addition, the technical registrations we are acquiring will provide us with a foundation of technologies upon
which we can build additional premix value-added products. AMVAC will immediately begin the transition of manufacturing, selling
and servicing these products.”
Mr. Wintemute concluded: “We expect that these products will increase full year domestic sales by 10 to 15%. Further, we believe
that our sales, marketing and product development capabilities will enable us to maintain all existing business and subsequently
expand our sales of these product lines in the years ahead.”
About American Vanguard
American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products
for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on
the Russell 2000® and Russell 3000® Indexes and the Standard & Poor’s Small Cap 600 Index. To learn more about American
Vanguard, please reference the Company’s web site at www.american-vanguard.com.
The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this
release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and
uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions,
changes in regulatory policy and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All
forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.
Company:
American Vanguard Corporation
William A. Kuser, 949-260-1200
Director of Investor Relations
williamk@amvac-chemical.com
or
Investor Representative:
The Equity Group Inc.
Lena Cati, 212-836-9611
Lcati@equityny.com
www.theequitygroup.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170606005317/en/